Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic microangiopathy

K Dahl-Jørgensen1

  • 1Aker Diabetes Research Centre, Paediatric Department, Aker University Hospital, Oslo, Norway.

Acta Paediatrica (Oslo, Norway : 1992). Supplement
|November 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease.

HLA·2017
Same author

Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes.

BMJ open diabetes research & care·2016
Same author

The associations between maternal pre-pregnancy body mass index or gestational weight change during pregnancy and body mass index of the child at 3 years of age.

International journal of obesity (2005)·2012
Same author

A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma.

Genes and immunity·2009
Same author

Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families.

Genes and immunity·2008
Same author

Sweets, snacking habits, and skipping meals in children and adolescents on intensive insulin treatment.

Pediatric diabetes·2008

Diabetic microangiopathy, including retinopathy and neuropathy, can affect children and adolescents. Optimal insulin treatment and regular screening are crucial for preventing these serious diabetes complications.

Area of Science:

  • Endocrinology
  • Diabetology
  • Pediatrics

Background:

  • Diabetic microangiopathy, encompassing retinopathy, nephropathy, and neuropathy, can manifest in children and adolescents.
  • Inadequate insulin treatment is a significant risk factor for developing these complications early.
  • The exact mechanisms are unknown but likely involve genetic factors and biochemical changes like increased protein glycation.

Purpose of the Study:

  • To review the mechanisms, screening, and management of diabetic microangiopathy in pediatric populations.
  • To emphasize the importance of early detection and intervention to prevent long-term complications.

Main Methods:

  • Review of existing literature on diabetic microangiopathy mechanisms, screening protocols, and intervention trials.
  • Analysis of functional and structural changes associated with the condition.

Related Experiment Videos

  • Discussion of screening recommendations for children and adolescents.

    • Main Results:

    • Key functional changes include altered organ blood flow, vascular permeability, blood viscosity, and platelet/endothelial function.
    • The structural hallmark is capillary basement membrane thickening, potentially leading to hypoxia and tissue damage.
    • Near-normoglycemia significantly reduces the risk of microangiopathy development and progression.

    Conclusions:

    • Early screening for microangiopathy is recommended for children and adolescents with diabetes.
    • Optimal insulin treatment and maintaining near-normal blood glucose levels are essential for preventing and managing diabetic microangiopathy.
    • Regular monitoring, including retinal, renal, and neurological assessments, is vital for early detection.